Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB16222Loncastuximab tesirine2Recruiting1